Zobrazeno 1 - 10
of 52
pro vyhledávání: '"M. Wutte"'
Autor:
W, Koglek, W, Kranig, M, Kowalski, D, Kronski, J, Brandl, A, Oberbichler, A, Suntinger, M, Wutte, G, Grimm, R, Grove, G, Lüdorff
Publikováno v:
HerzschrittmachertherapieElektrophysiologie. 11(4)
The individual adjustment of the AV intervals is a prerequisite for the hemodynamic advantages of dual-chamber pacing. The methods for the optimization of the AV-Delay (AVD) applied so far are time intensive. A simple and fast method is the approxima
Autor:
A.G Fraser, N Payne, C.F Madler, B Janerot-Sjoberg, B Lind, R.M Grocott-Mason, A.A Ionescu, N Florescu, U Wilkenshoff, P Lancellotti, M Wutte, L-A Brodin
Publikováno v:
European Heart Journal - Cardiovascular Imaging. 4:43-53
Autor:
M. Wutte, A. Suntinger, J. Brandl, G. Lüdorff, A. Oberbichler, W. Kranig, M. Kowalski, W. Koglek, R. Grove, D. Kronski, G. Grimm
Publikováno v:
Herzschrittmachertherapie + Elektrophysiologie. 11:244-253
Die bisher angewandten Methoden zur Optimierung der AV-Zeiten bei 2-Kammerschrittmacher erfordern einen gewissen apparativen Aufwand und sind zeitintensiv. Eine einfache und schnelle Methode ist die approximative Einstellung der AV-Intervalle mit Hil
Autor:
W. Kranig, W. Koglek, R. Grove, A. Oberbichler, M. Kowalski, G. Grimm, M. Wutte, E. Stammwitz, J. Brandl
Publikováno v:
Herzschrittmachertherapie und Elektrophysiologie. 15
Publikováno v:
Wiener klinische Wochenschrift. 113(3-4)
A single coronary ostium is traditionally considered to be of little clinical significance. We report a case of a single ostium in the right sinus of Valsalva, giving rise to the right coronary artery, from which the left main coronary artery origina
Autor:
H, Baumgartner, G, Porenta, Y K, Lau, M, Wutte, U, Klaar, M, Mehrabi, R J, Siegel, J, Czernin, G, Laufer, H, Sochor, H, Schelbert, M C, Fishbein, G, Maurer
Publikováno v:
Journal of the American College of Cardiology. 32(6)
We examined the relationship among viability assessment by dobutamine echocardiography (DE), positron emission tomography (PET) and thallium-201 single-photon emission computed tomography (TI-SPECT) to the degree of fibrosis.DE, PET and TI-SPECT have
[Improved kidney function with intravenous prostaglandin E1 in patients with terminal heart failure]
Publikováno v:
Wiener klinische Wochenschrift. 110(13-14)
In end stage congestive heart failure activation of a series of compensatory mechanisms increase renal vascular resistance and impair renal function. Prostaglandin E1 is increasingly used in the treatment of severe heart failure for its vasodilating
Autor:
Bernhard Frey, M. Schuller, B. Stanek, Martin Hülsmann, Richard Pacher, Engelbert Hartter, Sebastian Globits, E. Ogris, Rudolf Berger, M. Wutte
Publikováno v:
European heart journal. 17(8)
Angiotensin converting enzyme inhibitors improve symptoms and prolong life in congestive heart failure, but the dose in the individual patient is uncertain. A randomized, 48-week, double-blind study was performed to investigate the safety and efficac
Autor:
R, Pacher, S, Globits, M, Wutte, S, Rödler, G, Heinz, G, Kreiner, S, Radosztics, R, Berger, I, Presch, H, Weber
Publikováno v:
Critical care medicine. 22(7)
To study the hemodynamic effects of prostaglandin E1 (PGE1) administered in addition to a standard catecholamine infusion in patients with severe chronic heart failure.Prospective, placebo-controlled, randomized, single-blind study.Intensive care uni
Autor:
Jutta Bergler-Klein, Sebastian Globits, M. Wutte, Dietmar Glogar, William A. Baumgartner, E. Ogris, Richard Pacher, H. Teufelsbauer
Publikováno v:
European heart journal. 14(2)
Although angiotensin converting enzyme inhibitor therapy is an established approach in the treatment of chronic heart failure, the required dosage remains unclear. This open 6 month study investigated the influence of different captopril dosages on t